James Hardie Industries plc JHX
27.85 USD -0.81 (-2.83%)
At closeNov 6, 2026, 5:56 PM EST
29.11 +1.26 +4.52%
After hours · Nov 6, 5:56 PM ET
26.00 Day range 28.31
16.46 52-week range 31.43
- YTD
- +34.22%
- 1 year
- +60.61%
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 34.50 +23.9% upside
Now 27.85
- Target (low)
- 31.00
- Target (mean)
- 34.50
- Target (high)
- 40.00
Ratings (0m) 10 9 buy · 1 hold · 0 sell
- Strong buy0
- Buy9
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 10
- 1 month ago 10
- 2 months ago 10
- 3 months ago 9
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.25314 | 0.22013 – 0.28501 | 0.24 | +5.5% | 1.15B | -6.9% | 8 |
| Next quarter | 0.31426 | 0.26887 – 0.34 | 0.30 | +4.8% | 1.32B | -6.0% | 8 |
| Current year | 1.35 | 1.16 – 1.81 | 1.09 | +23.6% | 5.36B | +10.9% | 9 |
| Next year | 1.57 | 1.22 – 2.18 | 1.35 | +16.3% | 5.63B | +5.0% | 9 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 6, 2026 | Stephens & Co. | Maintained | Overweight | Overweight |
| Nov 6, 2026 | Truist Securities | Maintained | Buy | Buy |
| Oct 13, 2026 | Baird | Maintained | Outperform | Outperform |
| Oct 6, 2026 | Melius Research | Initiated | — | Buy |
| Sep 28, 2026 | Citigroup | Downgrade | Buy | Neutral |
| Sep 16, 2026 | Oppenheimer | Reiterated | Outperform | Outperform |
| Sep 14, 2026 | Loop Capital | Initiated | — | Buy |
| Aug 10, 2026 | Barclays | Upgrade | Equal-Weight | Overweight |
| Aug 7, 2026 | Stephens & Co. | Maintained | Overweight | Overweight |
| Aug 7, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Aug 7, 2026 | Truist Securities | Maintained | Buy | Buy |
| Jul 29, 2026 | Oppenheimer | Maintained | Outperform | Outperform |
| Jul 28, 2026 | Stephens & Co. | Maintained | Overweight | Overweight |
| Jul 24, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 14, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jun 26, 2026 | Stephens & Co. | Initiated | — | Overweight |
| May 21, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Apr 8, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Feb 12, 2026 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Feb 11, 2026 | Truist Securities | Maintained | Buy | Buy |
| Dec 8, 2025 | Barclays | Initiated | — | Equal-Weight |
| Nov 19, 2025 | Oppenheimer | Maintained | Outperform | Outperform |
| Nov 19, 2025 | Baird | Maintained | Outperform | Outperform |
| Nov 4, 2025 | Citigroup | Upgrade | Neutral | Buy |
| Oct 8, 2025 | Truist Securities | Maintained | Buy | Buy |
| Sep 30, 2025 | Wolfe Research | Initiated | — | Outperform |
| Aug 20, 2025 | Truist Securities | Maintained | Buy | Buy |
| Aug 20, 2025 | Baird | Maintained | Outperform | Outperform |
| Aug 8, 2025 | Jefferies | Initiated | — | Buy |
| Jul 28, 2025 | Macquarie | Upgrade | Neutral | Outperform |